Development of Glycosylation-Modified DPPA-1 Compounds as Innovative PD-1/PD-L1 Blockers: Design, Synthesis, and Biological Evaluation
Molecules · 2024
DOI: 10.3390/molecules29081898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Peng Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Novel Food Resources Processing Ministry of Agriculture, Key Laboratory of Agro-Products Processing Technology of Shandong Province…. Hauptthemen laut MEDLINE: B7-H1 Antigen, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, the Natural Science Foundation of Shandong Province, The Central Government Funds for Guiding Local Scientific and Technological Development.
Abstract (Originalsprache)
In the context of peptide drug development, glycosylation plays a pivotal role. Accordingly, L-type peptides were synthesized predicated upon the PD-1/PD-L1 blocker DPPA-1. Subsequent glycosylation resulted in the production of two distinct glycopeptides, D-glu-LPPA-1 and D-gal-LPPA-1, by using D-glucose (D-glu) and D-galactose (D-gal), respectively, during glycosylation. Both glycopeptides significantly inhibited the interaction between PD-1 and PD-L1, and the measured half maximal inhibitory concentrations (IC50s) were 75.5 μM and 101.9 μM for D-glu-LPPA-1 and D-gal-LPPA-1, respectively. Furthermore, D-gal-LPPA-1 displayed a pronounced ability to restore T-cell functionality. In an MC38 tumor-bearing mouse model, D-gal-LPPA-1 demonstrated a significant inhibitory effect. Notably, D-gal-LPPA-1 substantially augmented the abundance and functionality of CD8+ T cells in the tumor microenvironment. Additionally, in the lymph nodes and spleens, D-gal-LPPA-1 significantly increased the proportion of CD8+ T cells secreting interferon-gamma (IFN-γ). These strong findings position D-gal-LPPA-1 as a potent enhancer of the antitumor immune response in MC38 tumor-bearing mice, underscoring its potential as a formidable PD-1/PD-L1 blocking agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Novel Food Resources Processing Ministry of Agriculture, Key Laboratory of Agro-Products Processing Technology of Shandong Province, Institute of Agro-Food Science and Technology, Shandong Academy of A…
- College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, 263 Kaiyuan Road, Luoyang 471003, China.
- School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang 453007, China.
- Centre for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.
- School of Sciences, Henan University of Technology, Zhengzhou 450001, China.
ORCID-Profile: Jingjing Guo, Chune Peng
Förderung
- The National Natural Science Foundation of China
- the Natural Science Foundation of Shandong Province
- The Central Government Funds for Guiding Local Scientific and Technological Development
- the Innovation Project of Shandong Academy of Agricultural Sciences
- the Key Scientific Research Projects of Universities in Henan Province
- The Talent Introduction Fund
- Key Scientific Research Project Plan of Colleges and Universities in Henan Province
Zitieren
APA
Deng, P., Dong, X., Wu, Z., Hou, X., Mao, L., Guo, J., Zhao, W., Peng, C., Zhang, Z., & Peng, L. (2024). Development of Glycosylation-Modified DPPA-1 Compounds as Innovative PD-1/PD-L1 Blockers: Design, Synthesis, and Biological Evaluation. Molecules. https://doi.org/10.3390/molecules29081898
Vancouver
Deng P, Dong X, Wu Z, Hou X, Mao L, Guo J, et al. Development of Glycosylation-Modified DPPA-1 Compounds as Innovative PD-1/PD-L1 Blockers: Design, Synthesis, and Biological Evaluation. Molecules. 2024. doi:10.3390/molecules29081898
BibTeX
@article{Deng2024,
author = {Deng, Peng and Dong, Xiaodan and Wu, Ziyuan and Hou, Xixi and Mao, Longfei and Guo, Jingjing and Zhao, Wenshan and Peng, Chune and Zhang, Zhe and Peng, Lizeng},
title = {Development of Glycosylation-Modified DPPA-1 Compounds as Innovative PD-1/PD-L1 Blockers: Design, Synthesis, and Biological Evaluation},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29081898}
}
EUVIMED